Chargement en cours...
Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential
Studies demonstrate that lipid mediator 20-Hydroxyeicosatetraenoic acid (20-HETE) synthesis and signaling are associated with the growth of cancer cells in vitro and in vivo. Stable 20-HETE agonists promote the proliferation of cancer cells, whereas selective inhibitors of the 20-HETE-producing enzy...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3615879/ https://ncbi.nlm.nih.gov/pubmed/23569388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S31586 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|